• Manjil Gupta

Nanocarriers have emerged as versatile tools across diverse fields, including medicine, cosmetics, and agriculture. In the domain of drug delivery, nanofibers, nanoparticles, and nanotubes have demonstrated efficacy in diagnosing and treating diseases. Central to drug delivery is the optimization of pharmacokinetics and the achievement of therapeutic goals. Nanocarriers with submicron sizes offer advantages such as improved pharmacokinetics, reduced toxicity, enhanced solubility, and controlled release of therapeutic agents. The selection of nanocarriers hinges on factors such as the type of drug, physiological barriers, and site of action. Future research directions should emphasize stimuli-responsive drug release, address toxicity concerns, and broaden the spectrum of nanocarriers for diverse biomedical applications. This review provides a thorough exploration of nanocarriers, categorizing them into organic (liposomes, solid lipid nanocarriers, micelles, dendrimers, and polymeric nanocarriers), inorganic (gold nanoparticles, magnetic nanocarriers, quantum dots, and mesoporous silica), and hybrid nanocarriers.

VERSATILITY OF NANOCARRIERS IN DRUG DELIVERY: A REVIEW

"VERSATILITY OF NANOCARRIERS IN DRUG DELIVERY: A REVIEW", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.5, Issue 12, page no.608-615, December-2018, Available :http://www.jetir.org/papers/JETIR1812F07.pdf

"VERSATILITY OF NANOCARRIERS IN DRUG DELIVERY: A REVIEW", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.5, Issue 12, page no. pp608-615, December-2018, Available at : http://www.jetir.org/papers/JETIR1812F07.pdf